Drug Shortage Report for BIAXIN

Last updated on 2023-02-06 History
Report ID 181319
Drug Identification Number 02146908
Brand name BIAXIN
Common or Proper name CLARITHROMYCIN
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 55ML, 105ML
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-04-05
Actual start date
Estimated end date 2023-06-13
Actual end date 2023-02-02
Shortage status Avoided shortage
Updated date 2023-02-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-01-17 English Compare
v2 2023-01-17 French Compare
v3 2023-01-17 English Compare
v4 2023-01-17 French Compare
v5 2023-01-23 English Compare
v6 2023-01-23 French Compare
v7 2023-01-23 English Compare
v8 2023-01-23 French Compare
v9 2023-02-01 English Compare
v10 2023-02-01 French Compare
v11 2023-02-06 English Compare
v12 2023-02-06 French Compare

Showing 1 to 12 of 12